The estimated Net Worth of George Fennell is at least $3.47 Milione dollars as of 14 February 2024. George Fennell owns over 370 units of Idexx Laboratories stock worth over $3,472,021 and over the last 13 years George sold IDXX stock worth over $0.
George has made over 4 trades of the Idexx Laboratories stock since 2012, according to the Form 4 filled with the SEC. Most recently George exercised 370 units of IDXX stock worth $181,396 on 14 February 2024.
The largest trade George's ever made was exercising 9,810 units of Idexx Laboratories stock on 8 February 2024 worth over $608,220. On average, George trades about 1,851 units every 713 days since 2011. As of 14 February 2024 George still owns at least 7,082 units of Idexx Laboratories stock.
You can see the complete history of George Fennell stock trades at the bottom of the page.
George's mailing address filed with the SEC is ONE IDEXX DRIVE, , WESTBROOK, ME, 04092.
Over the last 21 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers e Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
Idexx Laboratories executives and other stock owners filed with the SEC include: